SRPT vs. ASM
Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and Avino Silver & Gold Mines Ltd. (ASM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SRPT or ASM.
Correlation
The correlation between SRPT and ASM is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SRPT vs. ASM - Performance Comparison
Loading data...
Key characteristics
SRPT:
-1.01
ASM:
2.37
SRPT:
-1.82
ASM:
3.26
SRPT:
0.72
ASM:
1.37
SRPT:
-0.89
ASM:
2.82
SRPT:
-2.05
ASM:
12.61
SRPT:
34.75%
ASM:
17.45%
SRPT:
70.36%
ASM:
78.07%
SRPT:
-98.17%
ASM:
-94.10%
SRPT:
-78.77%
ASM:
-25.58%
Fundamentals
SRPT:
$3.58B
ASM:
$377.69M
SRPT:
-$2.64
ASM:
$0.06
SRPT:
159.25
ASM:
0.00
SRPT:
1.60
ASM:
5.20
SRPT:
3.13
ASM:
3.00
SRPT:
$2.23B
ASM:
$53.79M
SRPT:
$1.81B
ASM:
$20.86M
SRPT:
-$117.73M
ASM:
$16.66M
Returns By Period
In the year-to-date period, SRPT achieves a -68.80% return, which is significantly lower than ASM's 226.90% return. Over the past 10 years, SRPT has underperformed ASM with an annualized return of 3.76%, while ASM has yielded a comparatively higher 9.43% annualized return.
SRPT
-68.80%
-29.47%
-63.75%
-71.12%
-18.90%
-24.05%
3.76%
ASM
226.90%
43.28%
150.43%
182.35%
62.59%
34.77%
9.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SRPT vs. ASM — Risk-Adjusted Performance Rank
SRPT
ASM
SRPT vs. ASM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Avino Silver & Gold Mines Ltd. (ASM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SRPT vs. ASM - Dividend Comparison
Neither SRPT nor ASM has paid dividends to shareholders.
Drawdowns
SRPT vs. ASM - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, roughly equal to the maximum ASM drawdown of -94.10%. Use the drawdown chart below to compare losses from any high point for SRPT and ASM. For additional features, visit the drawdowns tool.
Loading data...
Volatility
SRPT vs. ASM - Volatility Comparison
Sarepta Therapeutics, Inc. (SRPT) has a higher volatility of 40.97% compared to Avino Silver & Gold Mines Ltd. (ASM) at 25.30%. This indicates that SRPT's price experiences larger fluctuations and is considered to be riskier than ASM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SRPT vs. ASM - Financials Comparison
This section allows you to compare key financial metrics between Sarepta Therapeutics, Inc. and Avino Silver & Gold Mines Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SRPT vs. ASM - Profitability Comparison
SRPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a gross profit of 607.29M and revenue of 744.86M. Therefore, the gross margin over that period was 81.5%.
ASM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Avino Silver & Gold Mines Ltd. reported a gross profit of 10.46M and revenue of 24.38M. Therefore, the gross margin over that period was 42.9%.
SRPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported an operating income of -300.39M and revenue of 744.86M, resulting in an operating margin of -40.3%.
ASM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Avino Silver & Gold Mines Ltd. reported an operating income of 8.27M and revenue of 24.38M, resulting in an operating margin of 33.9%.
SRPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sarepta Therapeutics, Inc. reported a net income of -447.51M and revenue of 744.86M, resulting in a net margin of -60.1%.
ASM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Avino Silver & Gold Mines Ltd. reported a net income of 5.09M and revenue of 24.38M, resulting in a net margin of 20.9%.